Skip to main content

New Dementia Performance Measures: Opportunity for Public Comment


The AMA Physician Consortium For Performance Improvement has released a draft set of performance measures for persons with dementia. The draft is now open for public comments. It is likely that these performance measures will be influential. For example, I would not be surprised to see the VA implement many of these measures. The measures would benefit from comments by the GeriPal community. The multidisciplinary perspectives many of you can offer are likely to have a positive impact on the care of patients with dementia.

My initial overall impression of these performance measures is quite positive. They propose reasonable approaches that will improve the assessment and management of persons with dementia. The proposed performance measures encompass the following concerns:

Encouraging providers to stage the severity of dementia
Encouraging the use of standardized measures of cognitive assessment
Encouraging assessment of functional status
Encouraging better assessment and management of behavioral disturbances
Encouraging periodic screening for depression
Encouraging better counseling for safety concerns, including driving
Encouraging end of life counselling and advance care planning
Encouraging better caregiver education and support

In general, these measures concentrate on reasonable measures that should be part of the routine assessment and management of persons with dementia. Regular implementation of these measures would improve the quality of care of most patients and their caregivers.

My initial two suggestions for improvement are as follows:

  1. Discourage routine cancer screening in patients with dementia of moderate or worse severity. Their are two reasons for this recommendation. First, patients with dementia are much more likely to be harmed by routine screening than benefit. The lower life expectancy of advanced dementia makes it very unlikely detection and treatment of early stage cancer will improve survival. On the other hand, the potential harms of the screening test and downstream workup are accentuated in this population. Second, cancer screening in these patients is a potential red flag that raises general concerns about the quality of care. It at least suggests that the patient's care is not individualized to their needs. The provision of care that is at best not helpful, and at worst harmful makes it more likely that needed care is not being administered. See this post for more on this issue.
  2. Expand focus on end of life planning to more systematic focus on quality of life and palliation: Certainly, the focus on end of life planning is appropriate. But the performance measure needs to account for the importance of palliative management throughout the course of dementia, which can last many years. For example, there should be documentation of symptomatic distress. Many symptoms such as pain will not be directly caused by dementia, but will have a profound effect on disease management and quality of life. Similarly, the performance measure should note the need to move beyond simple documentation of preferences for specific decisions, such as DNR, hospitalization, and document more general values and preferences, such as whether qualify of life or longevity is more important. As recently described by Sudore and Fried (and discussed on GeriPal), new paradigms of end of life decision making focus less on documentation of specific preferences, and more on preparing caregivers for in the moment decision making.
All in all, these performance measures have the potential to improve care for patients with dementia. It is laudable that the developers are seeking comment, and GeriPalers could have a positive impact by weighing in with their thoughts.

by: Ken Covinsky

Comments

Popular posts from this blog

Geroscience and it's Impact on the Human Healthspan: A podcast with John Newman

Ok, I'll admit it. When I hear the phrase "the biology of aging" I'm mentally preparing myself to only understand about 5% of what the presenter is going to talk about (that's on a good day).  While I have words like telomeres, sirtuins, or senolytics memorized for the boards, I've never been able to see how this applies to my clinical practice as it always feels so theoretical.  Well, today that changed for me thanks to our podcast interview with John Newman, a "geroscientist" and geriatrician here at UCSF and at the Buck Institute for Research on Aging.

In this podcast, John breaks down what geroscience is and how it impacts how we think about many age-related conditions and diseases. For example, rather than thinking about multimorbidity as the random collection of multiple different clinical problems, we can see it as an expression of the fundamental mechanisms of aging. This means, that rather than treating individuals diseases, targeting …

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…